Patents by Inventor Andrew Richard Hilgenbrink

Andrew Richard Hilgenbrink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130266964
    Abstract: A method of detecting endothelial progenitor cells is provided. The method involves contacting a population of cells with a composition comprising a conjugate or complex of the formula Ab-X where the group Ab comprises a folate that binds to endothelial progenitor cells, and the group X comprises a fluorescent chromophore, and eliciting a fluorescent response from bound Ab-X.
    Type: Application
    Filed: June 5, 2013
    Publication date: October 10, 2013
    Inventors: Philip Stewart LOW, Andrew Richard HILGENBRINK
  • Publication number: 20100226967
    Abstract: The invention relates to a method of treating or diagnosing a disease state worsened by progenitor cells. The method utilizes a composition comprising a conjugate or complex of the general formula Ab-X wherein the group Ab comprises a vitamin, or an analog thereof, that binds to progenitor cells, and when the conjugate is being used for treatment of the disease state, the group X comprises an antigen, a cytotoxin, or a compound capable of altering progenitor cell function, and when the conjugate is being used for diagnosing the disease state, the group X comprises a quantifiable marker.
    Type: Application
    Filed: May 23, 2007
    Publication date: September 9, 2010
    Applicant: PURDUE RESEARCH FOUNDATION
    Inventors: Philip Stewart Low, Andrew Richard Hilgenbrink